On the Association Between Vitiligo and Malignant Melanoma

Lindelöf, B.; Hedblad, M-A.; Sigurgeirsson, B.
October 1998
Acta Dermato-Venereologica;10/28/98, Vol. 78 Issue 6, p483
Academic Journal
Examines the association between vitiligo and malignant melanoma. Etiology of squamous cell carcinomas; Clinical significance of the appearance of vitiligo-like depigmentations in melanoma patients; Role of melanin on the development of squamous cell carcinomas.


Related Articles

  • Vemurafenib.  // Reactions Weekly;7/6/2013, Issue 1460, p42 

    The article presents two case studies of women who developed vitiligo after being treated for metastatic melanoma.

  • Transfer of efficient anti-melanocyte T cells from vitiligo donors to melanoma patients as a novel immunotherapeutical strategy. Palermo, Belinda; Garbelli, Silvia; Mantovani, Stefania; Giachino, Claudia // Journal of Autoimmune Diseases (JAD);2005, Vol. 2, p7 

    Background: Vitiligo is a relatively common progressive depigmentary condition that is believed to be due to the autoimmune-mediated loss of epidermal melanocytes. High frequencies of self-reactive T lymphocytes directed toward melanocyte differentiation antigens are found in vitiligo patients...

  • Clinical Snippets.  // Journal of Investigative Dermatology;Dec2006, Vol. 126 Issue 12, p2557 

    The article presents abstracts of dermatology research. They include "Temperature Switch Triggers Itch," "Vitiligo and Enhanced Melanoma Survival" and "Niacin Releases PGD2 in Langerhans Cells.

  • Melanoma Survival Rate and Vitiligo. Alexander, Walter // Dermatology Times;Aug2003, Vol. 24 Issue 8, p22 

    Focuses on the median survival rate of patients receiving a novel immune-based maintenance biotherapy regimen for metastatic melanoma. Appearance of vitiligo; Stimulation of proliferation of dendritic cells and antigen-presenting cells with granulocyte-macrophage colony stimulating factor;...

  • Clinical clips. Pinkowish, Mary Desmond // Patient Care;5/15/1999, Vol. 33 Issue 9, p251 

    Summarizes research with immediate applications to the practice of dermatology. Improvements in melanoma survival; Better outlook for patients with thick melanoma; Acne, minocycline treatment and lupuslike syndrome; Benefits of laser resurfacing; Nonsurgical therapies for vitiligo.

  • Comparison of Cell-mediated Immunity to Melanoma Cells in Patients with Vitiligo, Halo Nevi or Melanoma. Mitchell, Malcolm S.; Nordlund, James J.; Lerner, Aaron B. // Journal of Investigative Dermatology;Aug80, Vol. 75 Issue 2, p144 

    Cell-mediated immunity of partially purified lymphocytes to cultivated melanoma cells was measured in vitro in patients with melanoma, vitiligo or halo net, or with nonpigmentary skin disorders, and in normal individuals. With a long-term line of melanoma cells labeled with 125I-IUDR it...

  • Enhanced Survival Associated with Vitiligo Expression during Maintenance Biotherapy for Metastatic Melanoma. Boasberg, Peter D.; Hoon, Dave S. B.; Piro, Lawrence D.; Martin, Maureen A.; Fujimoto, Akhide; Kristedja, Timothy S.; Bhachu, Sandeep; Xing Ye; Deck, Regina R.; O'Day, Steven J. // Journal of Investigative Dermatology;Dec2006, Vol. 126 Issue 12, p2658 

    Vitiligo, an autoimmune skin disorder, was evaluated in 49 metastatic melanoma patients treated with an immunotherapy regimen of maintenance biotherapy (mBT) following induction concurrent biochemotherapy (cBCT). Patients receiving mBT demonstrated a stable or better response to cBCT. The mBT...

  • MELANOMA IN SINCLAIR SWINE: A NEW ANIMAL MODEL. Millikan, Larry E.; Boylon, James L.; Hook, R. R.; Manning, P. J. // Journal of Investigative Dermatology;Jan1974, Vol. 62 Issue 1, p20 

    A new animal model for the study of melanocytic tumors is presented. A strain of miniature swine, bred for small size, has genetically determined tumors similar to many types of human pigment tumors, from benign junctional nevi to bizarre metastatic melanomas. Some tumors regress spontaneously...

  • Direct Evidence to Support the Role of Antigen-Specific CD8+ T Cells in Melanoma-Associated Vitiligo. Le Gal, Frédérique-Anne; Avril, Marie-Françoise; Bosq, Jacques; Lefebvre, Philippe; Deschemin, Jean-Christophe; Andrieu, Muriel; Dore, Martin-Xavier; Guillet, Jean-Gérard // Journal of Investigative Dermatology;Dec2001, Vol. 117 Issue 6, p1464 

    Vitiligo is a cutaneous pigmentary disorder characterized by the loss of melanocytes. An autoimmune mechanism is strongly suspected to be involved in this affection given that it is frequently associated with autoimmune hormonal disorders, and because antibodies directed against melanocytic...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics